Investing Profile

Beth Seidenberg

VCInvestor
Managing Director at Westlake Village BioPartners & General Partner at Kleiner Perkins
westlakebio.com/team/beth-sei...San Francisco, California
Photo of Beth Seidenberg, Managing Director at Westlake Village BioPartners
Kleiner Perkins Network
12 CONNECTIONS
cb
$2.0M - $50.0M
$25.0M
57
$820M
CompanyStageDateRound SizeTotal Raised
Star Therapeutics
Series CSep 2023$90M
$90M
Co-investors: Carl Gordon (OrbiMed), Maha Katabi (Sofinnova Investments)
Kyverna Therapeutics
Series BAug 2023$60M
Series BJan 2022$85M
Series AJan 2020$25M
$170M
Co-investors: Desmond Padhi (Westlake Village BioPartners), Shaan C. Gandhi (Northpond Ventures)
Kate Therapeutics
Series AJun 2023$51M
$51M
Co-investors: Clare Ozawa (Versant Ventures)
ACELYRIN
Series CSep 2022$300M
Series BNov 2021$250M
Series ADec 2020$8M
$560M
Co-investors: Richard Gaster (venBio), Dan Becker (Access Biotechnology), Sean Harper
ArsenalBio
Series BSep 2022$220M
Series AOct 2019$85M
$310M
Neuron23
Series CMar 2022$100M
Series ADec 2020$34M
Series BDec 2020$80M
$210M
Electra Therapeutics
Series BFeb 2022$84M
$84M
Co-investors: Carl Gordon (OrbiMed)
Expansion Therapeutics
Series BSep 2021$80M
Series AJan 2018$55M
$140M
Co-investors: Scott Rocklage (5am Ventures), Andrew Levin (RA Capital)
General Partner Kleiner Perkins2005 - Present